Citations

Showing 10 of 108104 citations.

Abstract 564: Adventitial Human Mesenchymal Stem Cells Transplantation Reduces Venous Neointimal Hyperplasia in an Experimental Murine AVF Model
Yang, Binxia , Brahmbhatt, Akshaar , Nieves-Torres, Evelyn, McCall, Deborah, Mukhopadhyay, Debabrata , Dietz, Allan B. , Misra, Sanjay

Mayo Clinic

Arteriosclerosis, Thrombosis, and Vascular Biology | March 19, 2022 | Volume: 34 | Issue: suppl_1 | Pages: No page available

10.1161/atvb.34.suppl_1.564 Get It

Introduction: Arteriovenous fistulas (AVFs) used for hemodialysis vascular access will fail because of venous neointimal hyperplasia (VNH) that causes stenosis formation at the venous outflow tract. As a result, only 60% of all AVFs are patent at 1-year. There are several factors which have been hypothesized to contribute to VNH including shear stress, hypoxia, and both local and systemic inflammation. Mesenchymal stem cells (MSCs) have been demonstrated to reduce inflammation while having antiproliferitive properties that aid abrogating vascular injury. Hypothesis: We hypothesized that adventitial transplantation of human adipose derived MSCs to the outflow vein of AVF created in CD1-FoxN1 would attenuate VNH failure by reducing pro-inflammatory mediators including tissue necrosis factor alpha (TNF-α), monocyte chemotactic protein-1 (MCP-1), and interleukin-1 beta (IL-1β). Methods: Adventitial transplantation of human MSC was performed in CD1-FoxN1 mice. A carotid artery to ipsilateral jugular AVF was placed and animals were divided into three groups: MSCs (M), CorMatrix ECM scaffold (S, CorMatrix Scaffold, Roswell, GE), or scaffold embedded with 250,000 MSCs (S+M) which were delivered to the adventitia. The mice were then sacrificed at 7 and 28 days post AVF placement and the outflow veins were harvested for histomorphometric and qPCR expression analysis. Results: The average lumen vessel area was significantly increased in the outflow veins removed from the S + M group compared to S or M alone at days 7 and 21 (both, P<0.05). The average area of neointima was significantly decreased in the S+M group when compared to S or M groups (P<0.05) while cell density and Ki-67 index were also significantly decreased at day 7 between S and S+M groups (P<0.05). RNA expression analysis revealed that MCP-1, IL-1β, and TNF-α were all significantly decreased in the outflow vein removed from the S+M group when compared to the S or M group (P<0.05). Conclusion: Adventitial transplantation of MSCs to the outflow vein of the AVF at the time of placement attenuates VNH mediated through a reduction of MCP-1, IL-1β, and TNF-α.
Abstract 500: Resting State Functional MRI Predicts Lesions When Diffusion-Weighted Imaging Fails in Ischemic Stroke
Kasam, Mallikarjun

Mayo Clinic

Arteriosclerosis, Thrombosis, and Vascular Biology | March 19, 2022 | Volume: 34 | Issue: suppl_1 | Pages: No page available

10.1161/atvb.34.suppl_1.500 Get It

Purpose: DWI is the current standard to identify and manage stroke. We assessed the hypothesis that resting state fMRI may detect the infarcts in patients with acute ischemic stroke more effectively than DWI. Methods: We studied 10 patients within 7 days of the acute onset of stroke patients retrospectively with an approved Institutional Review Board. All patients underwent multimodal MR imaging, including DWI and resting state fMRI sequences in the using a GE 3T MRI scanner. High resolution T2-weighted images were also acquired. The resting state fMRIs were processed using a published method by a single rater with extensive experience in neuroimaging data processing to avoid inter-rater variability. DWI data was analyzed using Analyze 11.0 software. Results: fMRI provides more accurate information on the irreversible status of ischemic brain tissue during an acute stroke compared with diffusion weighted imaging. Similar results were observed across all the 4 patients studied. Results: fMRI provides more accurate information on the irreversible status of ischemic brain tissue during an acute stroke compared with diffusion weighted imaging. Similar results were observed across all the 4 patients studied. Conclusion: The results of this project have direct clinical implications. fMRI show areas of damage when DWI has normalized after an acute ischemic stroke. DWI can normalize after showing an area of restricted diffusion in areas of the brain that is irreversibly injured. Therefore, fMRI reliably indicates damaged brain tissue in the setting of acute ischemic stroke where DWI is unable to detect. Such information is critical to make treatment decisions when considering which acute stroke patients should undergo reperfusion therapies. fMRI provides complimentary information to CT/MRI perfusion and has the potential to obviate the need of CT/MRI perfusion which are invasive, time and resource intensive. Our study is limited by their qualitative nature and small sample size.
Abstract 307: Estimation of Femoral Arterial Diameters in Men and Women Using New Postprocessing MR Angiographic Fly-Through Technique
Kasam, Mallikarjun

Mayo Clinic

Arteriosclerosis, Thrombosis, and Vascular Biology | March 19, 2022 | Volume: 34 | Issue: suppl_1 | Pages: No page available

10.1161/atvb.34.suppl_1.307 Get It

Background and Purpose: Development of the human vasculature database including femoral arterial parameters like maximum femoral artery diameter (MFAD), length, branching angles, etc for both men and women will be critical for Peripheral Arterial Disease (PAD) diagnosis for a treating clinician. Sporadic or limited work has been reported in clinical/pre-clinical research till date. This work was an important effort towards the development of human vasculature database using our newly developed method for estimation of stenosis 1 . Methods: Patient exams were performed under an IRB-approved protocol. Raw MR angiographic images of 30 male & 30 female PAD patients were retrospectively processed and analyzed for MFAD. The measurement includes healthy as well as symptomatic regions of interest at different femoral arterial sections. MR angiographies with 1mm3 spatial resolution were used for this work. Clinical exams were acquired on 3.0 T scanners (GE, DVMR 20.1IB, Milwaukee, WI). Data analysis: The angiogram was post-processed using tree analysis and virtual endoscopy modules of Analyze 11.0 software (Analyze 11.0; Biomedical Imaging Resource, Mayo Clinic, Rochester, MN) to fly through the femoral artery. A statistical parameter called Brightness Area Product (BAP) was defined as the sum of the intensities above the sample minimum intensity/threshold set by the user. This BAP is treated as a metric for the assessment of degree of stenosis. Different parameters were tested using 2-way Anova student t-test. Results and Discussions: A statistical significance (p<0.05) has been noticed for MFAD and linear arterial measurements among men and women for both healthy and symptomatic sections of the peripheral artery. More work towards the development and validation of this study is under progress. Reference: 1. New Reconstruction Technique for MRA to "Fly Through" the Lumen of the Cerebral Vasculature Mallikarjunarao Kasam; Siva S Ketha; Soumya Konduru, ATVB 2013, FL, USA, Abstract 273.
Abstract 291: Upregulation of Multiple DNA Methyltransferase Isoforms is Associated With Tissue Inflammation in Human Thoracic Aortic Aneurysm
Hagler, Michael A , Kunkala, Meghana R., Roos, Carolyn M, Sundt, Thoralf M. , Jbeli, A. , Miller, Jordan D.

Mayo Clinic

Arteriosclerosis, Thrombosis, and Vascular Biology | March 19, 2022 | Volume: 34 | Issue: suppl_1 | Pages: No page available

10.1161/atvb.34.suppl_1.291 Get It

Thoracic aortic aneurysm (TAA) is a degenerative condition of the aorta characterized by aortic dilatation secondary to tissue inflammation and matrix remodeling, which ultimately progresses to aortic dissection and rupture. While recent work suggests that in vitro exposure to pro-inflammatory stimuli promotes DNMT3b-dependent DNA methylation in skeletal muscle, epigenetic mechanisms regulating gene expression in TAA remain largely uncharacterized. We therefore tested the hypothesis that expression of tumor necrosis factor α (TNF-α) is increased in human TAA tissue and that such increases are associated with upregulation of DNA methyltransferase (DNMT) levels. Normal aortic samples (n=13) were acquired from non-aneurysmal hearts/aorta not suitable for cardiac transplant, whereas TAA samples from patients with tricuspid aortic valves (n=29) were acquired from patients undergoing elective surgery for aortic aneurysm. We measured relative expression of TNF-α, DNMT1, DNMT3a and DNMT3b mRNA levels in normal and TAA tissue by qRT-PCR, and DNMT3b protein levels by western blot. Marked increases in expression of the inflammatory marker TNF-α were noted in TAA tissue (12.3± 2.34), and were associated with significantly increased DNMT1 (1.4±0.13), DNMT3a (1.44±0.09) and DNMT3b (1.94±0.27) mRNA levels (p<0.05 for all). DNMT3b protein levels were also dramatically increased in human TAA samples (2.99±0.58-fold, n = 10/group, p<0.05) when compared to normal aortic tissue. Collectively, these data suggest a novel potential role for DNA methyltransferases as major regulators of altered gene expression in TAA, and support our working hypothesis that inflammation-induced increases in DNMT3b levels may be critical repressors of protective gene expression in TAA.
Abstract 270: Reduction of Mitochondrial Antioxidant Levels Augments Osteogenic Signaling Independent of Changes in Vasomotor Function in Aorta from Hypercholesterolemic Mice
Roos, Carolyn M, Hagler, Michael A , Zhang, Bin , Arghami, Arman , Miller, Jordan D.

Mayo Clinic

Arteriosclerosis, Thrombosis, and Vascular Biology | March 19, 2022 | Volume: 34 | Issue: suppl_1 | Pages: No page available

10.1161/atvb.34.suppl_1.270 Get It

Mitochondrial antioxidant genes are major regulators of oxidative stress in the vasculature. Previous data has shown that reducing antioxidant capacity accelerates atherosclerotic plaque size, however, it is unclear whether reducing mitochondrial antioxidant capacity alters plaque composition. Therefore, we tested the hypothesis that reductions of mitochondrial antioxidant capacity will increase osteogenic markers and intimal plaque calcification in aorta from hypercholesterolemic mice. We used Ldlr -/- ApoB 100/100 (LA) mice that were either wild-type (LA-MnSOD +/+ ) or heterozygous (LA-MnSOD +/- ) for manganese superoxide dismutase that were fed a Western Diet (TD88137) for 3 or 6 months. Changes in changes gene expression were assessed in aortic arch using qRT-PCR, plaque calcium levels were examined using histological evaluation from aortic cryosections, and endothelial function was measured using isolated organ bath chambers ( ex vivo ). While expression of SP7 (an osteogenic transcription factor) was unchanged between LA-MnSOD +/+ (1.0±0.6) and LA-MnSOD +/- (0.95±0.3) at 3 months, SP7 levels were dramatically increased in LA-MnSOD +/+ (8.0±2.8) at 6 months and increased further in LA-MnSOD +/+ mice (17.5±5.9; p<0.05). Alizarin Red staining for calcium showed increased calcium burden in plaques of 6 month LA-MnSOD +/- compared to LA-MnSOD +/+ (3636±669 pixels versus 649±206 pixels; p<0.05). Vasomotor function in aorta was unchanged between LA-MnSOD +/+ and LA-MnSOD +/- mice, suggesting that the transcriptional and functional changes related to calcification in LA-MnSOD +/- mice occur independently of nitric oxide signaling. In conclusion, our data strongly support our working hypothesis that reductions in mitochondrial antioxidant capacity significantly accelerate osteogenic calcification in aorta from hypercholesterolemic mice, and suggest that targeting mitochondrial oxidative stress may be a viable therapeutic strategy to slow vascular calcification.
Abstract 214: Effect of Intensive Lipid-Lowering Therapy on Epicardial Adipose Tissue in Patients Undergoing Pulmonary Vein Isolation for Atrial Fibrillation
Souček, Filip, Covassin, Naima , Ruzek, Lukas , Kára, Tomáš, Suleiman, Mahmoud , Koestler, Celeste, Friedman, Paul A. , Singh, Prachi , Somers, Virend K.

Mayo Clinic

Arteriosclerosis, Thrombosis, and Vascular Biology | March 19, 2022 | Volume: 34 | Issue: suppl_1 | Pages: No page available

10.1161/atvb.34.suppl_1.214 Get It

Background: The epicardial adipose tissue (EAT) has been identified as a sensitive marker of cardiometabolic risk. Recent evidence suggests efficacy of long-term statin therapy in reducing the EAT in patients with coronary artery disease. Whether the volume of EAT changes in patients with atrial fibrillation (AF) treated with a statin for a short time period is currently unknown. Methods: A population of AF patients undergoing pulmonary vein isolation was randomized to receive either 80 mg/day of atorvastatin (n=51, 44 males, age 55±10 years) or placebo (n=51, 41 males, age 56±10) for a 3 month period. EAT volume was assessed by cardiac computed tomography at baseline and after 3-month follow-up. Results: Patients randomized to statin treatment exhibited significant decreases in EAT volume (baseline vs follow-up: 105.8 ± 52.95 vs 103.05 ± 52.55 cm3, p = 0.05), C-reactive protein (2.97 ± 4.3 mg/L vs 2.03 ± 2.2 mg/L, p < 0.05), total cholesterol (182.5 ± 36.9 vs 129.3 ± 40.6 mg/dL, p < 0.001), and low density lipoprotein-cholesterol (111.88 ± 28 vs 61 ± 32.6 mg/dL, p < 0.001) at follow-up, while the body mass index did not vary (29.42 ± 5.2 vs 29.11 ± 4.8 kg/m2, p = 0.28). No changes were seen in the placebo group. Conclusions: Short-term high-dose statin therapy significantly reduced the volume of EAT in AF patients. EAT volume modulation might be an important mechanism by which statins may influence cardiovascular risk.
Abstract 164: The Role of IEX-1 in Venous Stenosis Formation Associated With Arteriovenous Fistula Used for Hemodialysis
Brahmbhatt, Akshaar , Yang, Binxia , Nieves-Torres, Evelyn, McCall, Deborah, Kumar, Rajiv, Mukhopadhyay, Debabrata , Misra, Sanjay

Mayo Clinic

Arteriosclerosis, Thrombosis, and Vascular Biology | March 19, 2022 | Volume: 34 | Issue: suppl_1 | Pages: No page available

10.1161/atvb.34.suppl_1.164 Get It

Purpose: The majority of patients with end stage renal disease who require hemodialysis use a arteriovenous fistula (AVF) for their vascular access. However, only 40% of AVFs are clinically usable after 1 year. Arteriovenous fistulas fail because of venous neointimal hyperplasia (VNH) that develops in the proximal outflow vein. The immediate early gene, IEX-1 (IER-3), is increased in response to shear stress and hypoxia and both factors contribute to VNH. IEX-1 expression was increased in stenotic venous stenoses removed from patients with hemodialysis vascular access compared to controls. We hypothesized that reducing the expression of IEX-1 using a knockout mouse model with chronic kidney disease (CKD) and AVFs would have decreased VNH compared to wild type (WT) mice. Methods: CKD was induced by performing a nephrectomy. Four weeks later, an AVF was placed to connect the carotid artery to ipsilateral jugular vein. The mice were sacrificed 3 and 28 days after fistula creation and outflow veins were harvested for gene expression and histomorphometric analyses. Results: By day 3, the average gene expression of vascular endothelial growth factor-A (VEGF-A) was significantly lower in the IEX-1 KO vs. WT mice (average reduction: 40%, P<0.05). At day 28, the average lumen vessel area was increased significantly (average increase: 133%, P<0.05, IEX-1 KO vs. WT, respectively) while the average area of the neointima was significantly decreased (average reduction: 20%, IEX-1 KO vs. WT, respectively). Accompanied with this, there was a significant decrease in α-SMA staining and Ki-67 proliferation while the average TUNEL staining was significantly increased (all P<0.05, IEX-1 KO vs. WT). Finally, there was a significant decrease in the average staining intensity for VEGF-A and matrix metalloproteinase-9 (MMP-9) in the KO vs. WT mice (both, P<0.05). Conclusion: A reduction in IEX-1 gene expression results in positive vascular remodeling accompanied with a reduction in proliferation and α-SMA density mediated through a VEGF-A/MMP-9 pathway. Taken collectively, these findings indicate that reducing IEX-1 expression is protective for VNH formation and provide a rationale for use of anti-IEX-1 therapies aimed at prolonging AVF function.
Abstract 440: Regional Differences in Fat Loss Following Weight Gain in Normal Adults
Romero‐Corral, Abel, Pusalavidyasagar, Snigdha , Davison, Diane E., Jensen, Michael D. , Singh, Prachi , Somers, Virend K. , Kuniyoshi, Fatima H. Sert

Mayo Clinic

Arteriosclerosis, Thrombosis, and Vascular Biology | March 19, 2022 | Volume: 32 | Issue: suppl_1 | Pages: No page available

10.1161/atvb.32.suppl_1.a440 Get It

Background: Normal weight adults gain leg fat gain via adipocyte hyperplasia and upper body subcutaneous (UBSQ) fat gain via adipocyte hypertrophy. Objective: To understand whether regional fat loss mirrors fat gain and whether leg fat loss results in decreased adipocyte number vs. size. Design: We assessed UBSQ, leg and visceral fat gain and loss in response to over- and underfeeding in 23 young, healthy normal weight adults (15 men). Participants gained ∼5% weight over 8 weeks and lost ∼80% of gained fat over the following 8 weeks. We measured abdominal subcutaneous and femoral adipocyte size and number after weight gain and loss. Results: Volunteers gained 3.1 ± 2.1 kg of body fat with overfeeding and lost 2.4 ± 1.7 kg with calorie restriction. Although upper body subcutaneous (UBSQ) fat and visceral fat gains were completely reversed with weight loss, leg fat had not yet returned to baseline values by 8 weeks. Abdominal and femoral adipocyte size decreased significantly with weight loss, but the number of adipocytes did not decrease. Abdominal adipocyte size decreases correlated (rho= 0.76, p = 0.001) with UBSQ fat mass decreases and femoral adipocyte size decreases correlated (rho= 0.49, p=0.05) with leg fat mass decreases. Conclusion: UBSQ and visceral fat depots increase and decrease proportionately with short term weight gain and loss, whereas gain and loss of leg fat are less well linked. Loss of lower body fat is due to reduced fat cell size, not number, which may result in long-term increases in leg fat cell number. This may have implications for long-term weight control.
Abstract 366: Sirtuin 6 Reduces Osteogenic Signaling in Aortic Valve Interstitial Cells and Vascular Smooth Muscle Cells
Zhang, Heyu , Greiten, Lawrence E. , Zhang, Bin , Miller, Jordan D.

Mayo Clinic

Arteriosclerosis, Thrombosis, and Vascular Biology | March 19, 2022 | Volume: 32 | Issue: suppl_1 | Pages: No page available

10.1161/atvb.32.suppl_1.a366 Get It

Cardiovascular calcification is often an active process involving re-differentiation of cells to an osteoblast-like phenotype, and is strongly associated with aging. Sirtuins are histone and protein deacetylases that play a critical role in a number of age-related diseases, and SIRT6-deficient mice have the most profound progeroid phenotype. The role of SIRT6 in the regulation of cardiovascular calcification, however, is poorly understood. We hypothesized that age-related reductions in sirtuins promote osteogenic differentiation in cells from aortic valve and aorta. We used aortic valve interstitial cells isolated from SIRT6-deficient mice, pigs, or humans, and vascular smooth muscle cells from mouse aorta to determine whether osteogenic differentiation of cardiovascular cells is regulated by SIRT6 levels. In line with our hypothesis, we found increased p-SMAD1/5/8 levels in cells from SIRT6-deficient aortic valve and aorta. Second, global SIRT inhibition with NAD+-depletion increased histone acetylation and protein levels of the osteogenic proteins Sp7 and Runx2. Third, inhibition of SIRTs enhanced the transcriptional responses of Sp7 and Runx2 when cells were treated with BMP2. Fourth, knockdown of SIRT6 in mouse and human aorta and aortic valve cells by RNA interference increased Sp7 expression. Finally, chronic pharmacological inhibition of SIRTs promoted calcified nodule formation and calcium deposition in cultured mouse/swine aortic valve cells. Collectively, our data suggest that reductions in SIRT6 levels favor amplification of pro-osteogenic signaling and osteogenic differentiation of cardiovascular cells and promote the formation of calcified nodules in vitro . These data also suggest that sirtuin re-activation may be a useful therapy to slow initiation and/or progression of cardiovascular calcification in vivo.
Abstract 270: Decrease of BNP Concentrations in Blood Perfusing Extremities of Patients with Advanced Peripheral Arterial Disease
Kurklinsky, Andrew K., Heublein, Denise M., Stockland, Andrew H., McPhail, Ian R., Friese, J., Andrews, James C. , Oderich, Gustavo S. , Burnett, John C. , Bjarnason, Haraldur , Misra, Sanjay , Oderich, Gustavo S.

Mayo Clinic

Arteriosclerosis, Thrombosis, and Vascular Biology | March 19, 2022 | Volume: 32 | Issue: suppl_1 | Pages: No page available

10.1161/atvb.32.suppl_1.a270 Get It

Rationale: The role of cardiac natriuretic peptides (NPs) in peripheral arterial disease (PAD) or thromboangiitis obliterans (TA) is unknown. Recent studies in mice suggested that BNP may be produced outside the heart in the ischemic limbs contributing to peripheral angiogenesis. Objective: Determine if synthesis or consumption/degradation of NPs occur in the ischemic legs of patients with PAD or TA. Methods: 32 patients with critical limb ischemia (CLI) or claudication (PAD n=31; TA n=1; 20 males; mean age 72.9 years) underwent diagnostic angiography or revascularization. We determined differences of concentrations of BNP, NT-proBNP, and CNP in the blood of proximal veins and arteries of both legs. Concentrations differences were then compared between the more ischemic target and the contralateral self-control legs. Results: Values are means ± SD. P values <0.05 were considered significant. In the PAD group, in the target extremity, concentration step-ups of NT-proBNP (11±68; p=0.40) and CNP (0.45±6.22; p=0.71) were not significant from the arterial to venous blood. In the contralateral self-control legs, NT-proBNP and CNP concentrations drops were also not significant (-37±160, p=0.7; -0.89±4.09, p=0.23). Venous BNP concentrations were significantly lower than arterial both in the target (-66±153, p<0.001) and self-control legs (-59±107, p<0.001). BNP concentrations drops were greater in the CLI than claudication cases driving the overall significance. In the patient with TA, whose only identifiable PAD risk factor was smoking, arterial concentrations of NPs were generally low (NT-proBNP 81; BNP 46; CNP 8.2), but higher than venous concentrations (80; 41; 6.7). Conclusion: Significantly lower venous BNP concentrations suggest possible BNP consumption/degradation in the ischemic legs. Concentrations of NT-proBNP, that has a longer half-life than BNP, were more stable suggesting no significant local production or conversion to BNP. CNP concentrations were stable. Recognizing the angiogenic properties of NPs and lack of evidence of peripheral production, studies are warranted in humans with PAD to determine the potential angiogenic properties of exogenous NPs supplementation in what could be considered a local NPs deficiency state.